TipRanks
Go Ultimate55% OFF

Innate Pharma SA (IPHYF) Balance Sheet

Innate Pharma SA Balance Sheet

Innate Pharma SA's total assets for Q2 2026 were $34.73M, a decrease of 44.63% from the previous quarter. IPHYF total liabilities were $75.23M for the fiscal quarter, a 10.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 62.72M$ 111.06M$ 184.19M$ 207.86M$ 267.50M
$ 84.42M$ 102.22M$ 132.29M$ 153.71M$ 160.06M
$ -21.70M$ 8.83M$ 51.90M$ 54.15M$ 107.44M

Currency in EUR

Innate Pharma SA Debt to Assets

0200M400M600M40 %80 %120 %160 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets